Trexquant Investment LP Athenex, Inc. Transaction History

Trexquant Investment LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$3.71 - $5.13 $136,272 - $188,430	-36,731 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$4.08 - $14.75 $29,600 - $107,011	7,255 Added 24.61%	36,731 $158,000
Q4 2020 Feb 11, 2021	SELL	$11.06 - $14.01 $157,262 - $199,208	-14,219 Reduced 32.54%	29,476 $326,000
Q3 2020 Nov 06, 2020	BUY	$10.26 - $14.55 $448,310 - $635,762	43,695 New	43,695 $529,000
Q1 2020 May 08, 2020	SELL	$5.71 - $15.85 $113,885 - $316,128	-19,945 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$9.6 - $17.75 $9,792 - $18,105	1,020 Added 5.39%	19,945 $305,000
Q3 2019 Nov 08, 2019	BUY	$12.16 - $21.0 $91,309 - $157,689	7,509 Added 65.78%	18,925 $230,000
Q2 2019 Aug 09, 2019	SELL	$9.44 - $19.8 $41,441 - $86,922	-4,390 Reduced 27.77%	11,416 $226,000
Q1 2019 May 13, 2019	BUY	$11.11 - $13.49 $175,604 - $213,222	15,806 New	15,806 $194,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.